<code id='207718A88A'></code><style id='207718A88A'></style>
    • <acronym id='207718A88A'></acronym>
      <center id='207718A88A'><center id='207718A88A'><tfoot id='207718A88A'></tfoot></center><abbr id='207718A88A'><dir id='207718A88A'><tfoot id='207718A88A'></tfoot><noframes id='207718A88A'>

    • <optgroup id='207718A88A'><strike id='207718A88A'><sup id='207718A88A'></sup></strike><code id='207718A88A'></code></optgroup>
        1. <b id='207718A88A'><label id='207718A88A'><select id='207718A88A'><dt id='207718A88A'><span id='207718A88A'></span></dt></select></label></b><u id='207718A88A'></u>
          <i id='207718A88A'><strike id='207718A88A'><tt id='207718A88A'><pre id='207718A88A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:8
          Illustration of doctors and researchers using innovative technologies for medicine and healthcare with artificial intelligence. -- health tech coverage from STAT
          Adobe

          At first glance, the Coalition for Health AI looks like any technology lobbying group. Its membership — including Microsoft, Google, and many of the nation’s largest academic hospitals — forms a formidable presence in Washington.

          But on Monday, the coalition forged a different deal with federal regulators. It will work with them to develop quality and safety standards for artificial intelligence, an experiment that will test whether industry and government can effectively partner in the regulation of a fast-moving technology.

          advertisement

          The nonprofit announced that its board of directors will include leaders from the Food and Drug Administration and the Office of the National Coordinator for Health Information Technology — agencies that, until now, have been setting up guardrails for AI in health care on their own. Government staffers will now work alongside industry scientists to develop evaluation methods and address new questions posed by generative AI and its emerging applications.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes
          U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

          DarronCummings/APLONDON—AU.K.governmentagencyonTuesdaysaidthatitwon’trecommendEliLilly’sMounjaro—par

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Lawsuit challenges CMS nursing home minimum staffing rule

          JeffChiu/APAnewfederallawsuitchallengingtheBidenadministration’snewminimumnursinghomestaffingrulelay